Philip N. Patsalos is Professor of Clinical Pharmacology at University College London's Institute of Neurology and Director of the Therapeutic Drug Monitoring Unit based at the Chalfont Centre for Epilepsy, Chalfont St Peter. He has more than 200 publications, has served on International League Against Epilepsy (ILAE) committees, and is currently Associate Editor of Epilepsia and of Therapeutic Drug Monitoring as well as Deputy Editor of the Journal of Epileptology. He was recently awarded the 2016 Excellence in Epilepsy Lifetime Achievement Award by the British Branch International League against Epilepsy (ILAE) for his contribution to epilepsy care and research. Erik K. St Louis is Associate Professor of Neurology and Consultant in Neurology at the Mayo Clinic College of Medicine and Science in Rochester, Minnesota. He previously co-directed the comprehensive epilepsy programs at Marshfield Clinic, Wisconsin, and the University of Iowa, and has recently co-edited two books on epilepsy and EEG. His research interests include the relationships between sleep and epilepsy and the parasomnias.

• 1. Acetazolamide; 2. ACTH; 3. Brivaracetam; 4. Carbamazepine; 5. Clobazam; 6. Clonazepam; 7. Diazepam; 8. Eslicarbazepine; 9. Ethosuximide; 10. Felbamate; 11. Fosphenytoin; 12. Gabapentin; 13. Lacosamide; 14. Lamotrigine; 15. Levetiracetam; 16. Lorazepam; 17. Methsuximide; 18. Midazolam; 19. Oxcarbazepine; 20. Paraldehyde; 21. Perampanel; 22. Phenobarbital; 23. Phenytoin; 24. Piracetam; 25. Pregabalin; 26. Primidone; 27. Rufinamide; 28. Stiripentol; 29. Sulthiame; 30. Tiagabine; 31. Topiramate; 32. Valproate; 33. Vigabatrin; 34. Zonasimide.

Select Guide Rating